312 related articles for article (PubMed ID: 25052080)
21. Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia.
Adam B; Liebregts T; Saadat-Gilani K; Vinson B; Holtmann G
Aliment Pharmacol Ther; 2005 Aug; 22(4):357-63. PubMed ID: 16098003
[TBL] [Abstract][Full Text] [Related]
22. In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.
Farré R; Vanheel H; Vanuytsel T; Masaoka T; Törnblom H; Simrén M; Van Oudenhove L; Tack JF
Gastroenterology; 2013 Sep; 145(3):566-73. PubMed ID: 23702005
[TBL] [Abstract][Full Text] [Related]
23. Do we have an alternative for the Rome III gastroduodenal symptom-based subgroups in functional gastroduodenal disorders? A cluster analysis approach.
Van Oudenhove L; Holvoet L; Vandenberghe J; Vos R; Tack J
Neurogastroenterol Motil; 2011 Aug; 23(8):730-8. PubMed ID: 21447145
[TBL] [Abstract][Full Text] [Related]
24. Functional Dyspepsia: Advances in Diagnosis and Therapy.
Talley NJ
Gut Liver; 2017 May; 11(3):349-357. PubMed ID: 28452210
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia.
Fischler B; Tack J; De Gucht V; Shkedy ZI; Persoons P; Broekaert D; Molenberghs G; Janssens J
Gastroenterology; 2003 Apr; 124(4):903-10. PubMed ID: 12671886
[TBL] [Abstract][Full Text] [Related]
26. Editorial: Reflux, dyspepsia, and Rome III (or Rome IV?).
Stanghellini V; Frisoni C
Am J Gastroenterol; 2010 Dec; 105(12):2632-4. PubMed ID: 21131930
[TBL] [Abstract][Full Text] [Related]
27. The ageing gut: diminished symptom response to a standardized nutrient stimulus.
Gururatsakul M; Holloway RH; Adam B; Liebregts T; Talley NJ; Holtmann GJ
Neurogastroenterol Motil; 2010 Mar; 22(3):246-e77. PubMed ID: 19814772
[TBL] [Abstract][Full Text] [Related]
28. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
McColl E; Junghard O; Wiklund I; Revicki DA
Am J Gastroenterol; 2005 Jan; 100(1):11-8. PubMed ID: 15654774
[TBL] [Abstract][Full Text] [Related]
29. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort.
Walker MM; Aggarwal KR; Shim LS; Bassan M; Kalantar JS; Weltman MD; Jones M; Powell N; Talley NJ
J Gastroenterol Hepatol; 2014 Mar; 29(3):474-9. PubMed ID: 24304041
[TBL] [Abstract][Full Text] [Related]
30. Current and emerging therapeutic options for the management of functional dyspepsia.
Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
[No Abstract] [Full Text] [Related]
31. Gastric Activity and Gut Peptides in Patients With Functional Dyspepsia: Postprandial Distress Syndrome Versus Epigastric Pain Syndrome.
Russo F; Chimienti G; Clemente C; Riezzo G; D'Attoma B; Martulli M
J Clin Gastroenterol; 2017 Feb; 51(2):136-144. PubMed ID: 27092429
[TBL] [Abstract][Full Text] [Related]
32. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea.
Lee KJ; Demarchi B; Demedts I; Sifrim D; Raeymaekers P; Tack J
Am J Gastroenterol; 2004 Sep; 99(9):1765-73. PubMed ID: 15330916
[TBL] [Abstract][Full Text] [Related]
33. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
[TBL] [Abstract][Full Text] [Related]
34. Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care.
Van den Houte K; Carbone F; Goelen N; Schol J; Masuy I; Arts J; Caenepeel P; Staessen D; Vergauwe P; Van Roey G; Latour P; Piessevaux H; Maldague P; Gerkens A; Wuestenberghs F; Vandenberghe A; Tack J
Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1620-1626. PubMed ID: 32645450
[TBL] [Abstract][Full Text] [Related]
35. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States.
Shaib Y; El-Serag HB
Am J Gastroenterol; 2004 Nov; 99(11):2210-6. PubMed ID: 15555004
[TBL] [Abstract][Full Text] [Related]
36. Defining functional dyspepsia.
Mearin F; Calleja JL
Rev Esp Enferm Dig; 2011 Dec; 103(12):640-7. PubMed ID: 22217348
[TBL] [Abstract][Full Text] [Related]
37. Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.
Tack J; Talley NJ
Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):134-41. PubMed ID: 23399526
[TBL] [Abstract][Full Text] [Related]
38. Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores.
Lacy BE; Everhart K; Crowell MD
Dig Dis Sci; 2019 May; 64(5):1281-1287. PubMed ID: 30382539
[TBL] [Abstract][Full Text] [Related]
39. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
40. Functional gastroduodenal disorders.
Tack J; Talley NJ; Camilleri M; Holtmann G; Hu P; Malagelada JR; Stanghellini V
Gastroenterology; 2006 Apr; 130(5):1466-79. PubMed ID: 16678560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
